Differential analysis of the enrichment score revealed that the CD74 high expression group was significantly enriched in various cancers, such as small lung cancer, non-small cell lung cancer, pancreatic cancer, and others, within the KEGG gene set. This evidence concerns the gene CD74 and pancreatic neoplasm.